A pharmaceutical composition for treatment of wounds is disclosed in the present invention. The pharmaceutical composition is Bispecific Agonist (BA) proteins comprising an Interleukin-7 (IL-7) and an epidermal growth factor (EGF) for treatment of acute or chronic wounds as well as immune suppressive conditions in p...